• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC UNK_QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC UNK_QDOT MICRO; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number UNK_QDOT MICRO
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Arrest (1762); Stenosis (2263); Thrombosis/Thrombus (4440)
Event Date 11/14/2023
Event Type  Death  
Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Event Description
It was reported that a patient underwent a ventricular tachycardia / premature ventricular complex ablation procedure using qdot catheter.The patient experienced cardiac arrest, coronary artery stenosis that required coronary angiogram with intra-arterial nitroglycerin, cpr and extra corporeal membrane oxygenation (ecmo).It was also reported that the patient had a "clot" in the left ventricle (lv).After first mapping and ablating with the qdot micro catheter in the right ventricular outflow tract (rvot), after multiple ablation attempts the physician accessed the left ventricular outflow tract (lvot) from a retrograde aortic approach.A new lvot map was created and four rf (radiofrequency) applications were made high in the lvot, near the aortic cusps.Mapping continued for thirty minutes for continuing premature ventricular contraction's (pvc), until a left bundle branch block (lbbb) was noticed on electrocardiogram (ekg), the patient's blood pressure dropped to 40's over 20's (40's systolic/20's diastolic).In addition, intracardiac echo (ice) revealed decreased lv movement.No pericardial effusion was present on ice.Cpr was initiated, a code was called ("code medications" were administered), multiple defibrillations were given for fine ventricular fibrillation, and an ecmo (extracorporeal membrane oxygenation) code team was called into the lab.The initial angiogram revealed closure of the left main coronary artery.Nitroglycerine was pushed directly into the left main artery and ecmo was started.The post-intervention angiogram revealed that the left main coronary artery was open.The patient's pressure stabilized on ecmo.At the time of the call the patient was in a viable rhythm, remained on ecmo, and they would soon be transferred to the icu.Based on interventional cardiologist comments, the cause of the event was uncertain, the left main had ostial narrowing, suggesting there may have been a coronary spasm or clot.Patient stabilized on ecmp but later expired in the icu.Secondhand information from staff stated that clot was found in the left ventricle (lv).Pt was anticoagulated.Activated clotting times (act) are performed at regular intervals.Act values are unavailable.There were no error messages on bwi product.The physician did not see any product problem.Generator parameters included qmode ablation at 50 w with default parameters.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNK_QDOT MICRO
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key18304022
MDR Text Key330190946
Report Number2029046-2023-02907
Device Sequence Number1
Product Code OAE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P210027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/11/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_QDOT MICRO
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/11/2023
Initial Date FDA Received12/11/2023
Supplement Dates Manufacturer Received12/11/2023
Supplement Dates FDA Received12/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CARTO 3 SYSTEM; NGEN GENERATOR; NGEN PUMP
Patient Outcome(s) Life Threatening; Hospitalization; Required Intervention; Death;
Patient Age70 YR
Patient SexFemale
-
-